FDA Approved: ARBLI — Supplemental Application (Scienture LLC)

View source ↗

Summary

FDA approved a supplemental application for ARBLI (losartan potassium) filed by Scienture LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Heart Failure
• Hypertension
• Stroke

Drugs mentioned

• ARBLI (Losartan Potassium)

Snippet

SUPPL AP for ARBLI (LOSARTAN POTASSIUM)